Formula For Calculation Of eGFR In Males Is:
| From: | To: |
The CKD-EPI 2021 (Chronic Kidney Disease Epidemiology Collaboration 2021) equation estimates glomerular filtration rate (GFR) from serum creatinine and age specifically for male patients. This updated version provides improved accuracy in GFR estimation compared to previous equations.
The calculator uses the CKD-EPI 2021 equation for males:
Where:
Explanation: The equation accounts for the non-linear relationship between creatinine and GFR, with optimized coefficients specifically calibrated for male patients using updated data.
Details: Accurate GFR estimation is crucial for diagnosing chronic kidney disease in males, determining disease stage, guiding medication dosing, and monitoring kidney function over time.
Tips: Enter serum creatinine in mg/dL and age in years. All values must be valid (creatinine > 0, age between 1-120 years). This calculator is specifically designed for male patients.
Q1: Why Use CKD-EPI 2021 Instead Of Older Equations?
A: The CKD-EPI 2021 equation incorporates more recent data and provides improved accuracy across the entire GFR range, with better performance in diverse populations.
Q2: What Are Normal eGFR Values For Males?
A: Normal eGFR is generally ≥90 mL/min/1.73m², though values naturally decline with age. Values below 60 mL/min/1.73m² for 3+ months indicate chronic kidney disease.
Q3: When Should Creatinine Be Measured For Accurate Results?
A: Morning fasting samples are ideal, but random samples are acceptable. Avoid testing shortly after meat-heavy meals or vigorous exercise as these can temporarily elevate creatinine levels.
Q4: Are There Limitations To This Equation For Males?
A: The equation may be less accurate in extremes of age, amputees, patients with very high or low muscle mass, and those with rapidly changing kidney function.
Q5: Can This Calculator Be Used For Females?
A: No, this specific equation is calibrated for male patients only. Use the appropriate CKD-EPI 2021 equation for females for accurate results.